Cocrystal Solubility Advantage Diagrams as a Means to Control Dissolution, Supersaturation, and Precipitation-Reference-Cited by-同舟云学术

Cocrystal Solubility Advantage Diagrams as a Means to Control Dissolution, Supersaturation, and Precipitation

Published:2019-07-18 Issue:9 Volume:16 Page:3887-3895
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Huang Yaohui¹,Kuminek Gislaine²^ORCID,Roy Lilly²,Cavanagh Katie L.²^ORCID,Yin Qiuxiang¹^ORCID,Rodríguez-Hornedo Naír²^ORCID

Affiliation:

1. School of Chemical Engineering and Technology, Key Laboratory for Modern Drug Delivery and High Efficiency, Tianjin University, Tianjin 300072, People’s Republic of China

2. Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, United States

Funder

Natural Science Foundation of Tianjin City

College of Pharmacy, University of Michigan

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b00501

Reference48 articles.

1. Supramolecular Architectures of Meloxicam Carboxylic Acid Cocrystals, a Crystal Engineering Case Study

2. Solubility Advantage of Pharmaceutical Cocrystals

3. Cocrystals of Quercetin with Improved Solubility and Oral Bioavailability

4. Pharmaceutical cocrystals and poorly soluble drugs

5. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Going beyond the Ordered Bulk: A Perspective on the Use of the Cambridge Structural Database for Predictive Materials Design;Crystal Growth & Design;2024-08-19

2. Revolutionizing Antiviral Therapeutics: Unveiling Innovative Approaches for Enhanced Drug Efficacy;International Journal of Nanomedicine;2024-03

3. Quabodepistat (OPC-167832), a Novel Antituberculosis Drug Candidate: Enhancing Oral Bioavailability via Cocrystallization and Mechanistic Analysis of Bioavailability in Two Cocrystals;Molecular Pharmaceutics;2023-12-15

4. Exploration of different solid variants of the anticancer medication Panobinostat (PNB) with improved physicochemical attributes;Journal of Molecular Structure;2023-11

5. An In Vitro Model for Cocrystal Dissolution with Simultaneous Surface and Bulk Precipitation;Molecular Pharmaceutics;2023-10-26